Search arXiv⌕ Search

arXiv · 2610.39447

Comparison of anomaly detection and supervised learning for acute myeloid leukemia blast identification: A proof-of-concept study

Abstract

Background. Flow cytometry is the established standard for identifying leukemic blast populations in AML, but relies predominantly on subjective, time-consuming manual gating. Machine learning approaches are being explored to support automated blast detection, yet the relative performance of anomaly detection versus supervised classification remains incompletely characterized. Methods. We compared six computational approaches for blast identification: four anomaly detection algorithms (Isolation Forest, One-Class SVM, Local Outlier Factor, Half-Space Trees), a supervised Random Forest classifier, and an unsupervised UMAP-HDBSCAN clustering approach. The models were developed on the BLAST110 cohort (110 samples) using nested cross-validation with patient-level grouping, and externally validated on two independent LAIP29 samples spanning high (about 41%) and low (about 1%) blast prevalence. Results. Random Forest achieved the strongest external validation performance (F1 = 0.965 diagnostic sample; F1 = 0.587 follow-up sample). Anomaly detection methods showed weaker, more variable performance, with substantial further decline at low blast prevalence (F1 as low as 0.0006); One-Class SVM performed best among anomaly detectors (F1 = 0.731, diagnostic sample). Several models showed a marked drop in performance between cross-validation and external validation. UMAP-HDBSCAN clustering failed to separate blast and non-blast populations into distinct clusters. Conclusions. Supervised classification substantially outperformed the anomaly detection and unsupervised clustering approaches evaluated here, contrasting with prior work favoring anomaly detection for AML blast identification. This divergence may reflect differences in anomaly detection design; label-efficient approaches may still hold practical value where labeled data collection is limited.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mezya Sezen, Pavinap Priyaa, Krishnapriya Vinod, Atul Thatai, Nitin Dayal, Ragothaman M. Yennamalli, Rama S. Akondy. 2026-10-29. Comparison of anomaly detection and supervised learning for acute myeloid leukemia blast identification: A proof-of-concept study. https://arxiv.org/abs/2610.39447

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

FISH Omics Format: a standard enabling FAIR chromatin tracing data sharing across repositories

In recent years, multiplexed Fluorescence In Situ Hybridization (FISH) or FISH-omics methods have rapidly expanded, enabling the quantification of chromatin organization in single cells, often in conjunction with measurements of RNAs and proteins. These approaches have deepened our understanding of how 3D chromosome architecture relates to transcriptional activity and cell states in health and disease. Despite these advances, results from Chromatin Tracing FISH-omics experiments remain challenging to share, reuse, and analyze due to the absence of standardized data exchange specifications. Building on the release of microscopy metadata standards, we introduce the FISH Omics Format-Chromatin Tracing (FOF-CT), a community-developed standard for processed results from diverse imaging modalities. We describe the FOF-CT file format and present a curated collection of datasets deposited in the 4D Nucleome Data Portal and the OME Image Data Resource (IDR). We also highlight their potential for reuse, integration, and modeling by outlining example analysis pipelines and illustrating biological insights enabled by standardized, FAIR-compliant Chromatin Tracing datasets. FOF-CT natively represents both ball-and-stick and volumetric Chromatin Tracing data, unifying the two modalities within a single, modular table-based architecture (FOF-bas-CT and FOF-vol-CT, respectively).

q-bio.OT↗

Drug-Associated Rhabdomyolysis in the FDA Adverse Event Reporting System (FAERS): A Disproportionality Analysis

This study aimed to systematically identify and quantify risks for drug-induced rhabdomyolysis (DIR) using real-world data and to propose an evidence-based risk mitigation framework. We conducted a retrospective pharmacovigilance study using the FDA Adverse Event Reporting System (FAERS) database from Q1 2005 to Q1 2025. A two-stage analysis involved initial signal detection using the Reporting Odds Ratio (ROR), followed by a LASSO-optimized multivariate logistic regression to calculate adjusted odds ratios (aORs) for 54 target drugs while controlling for confounders. Our analysis confirmed potent DIR risks for known agents, such as gemfibrozil (aOR 173.67) and statins (lovastatin aOR 97.20, simvastatin aOR 85.12). Crucially, we identified strong, novel risk signals for drugs currently lacking warnings, most notably levetiracetam (aOR 11.02) and donepezil (aOR 8.90). A significant "labeling gap" was quantified: 61.1% of drugs with a statistically significant DIR risk lack a corresponding warning in U.S. drug labels. We subsequently developed a three-tiered risk stratification model. The proposed framework provides a data-driven foundation for developing tiered clinical decision support systems, enhancing prescribing safety, and guiding future regulatory action to bridge the identified evidence-to-labeling gap.

q-bio.OT↗

Current validation practice undermines surgical AI development

Surgical data science (SDS) is rapidly advancing, yet clinical adoption of artificial intelligence (AI) in surgery remains limited, with inadequate validation as an important contributing factor. Existing validation practices often neglect the temporal and hierarchical structure of intraoperative videos, yielding misleading or clinically irrelevant results. We introduce a comprehensive catalogue of validation pitfalls in AI-based surgical video analysis, derived from a multi-stage Delphi process with 92 international experts. Pitfalls span three categories: (1) data, (2) metric selection/configuration, and (3) aggregation and reporting. A systematic review of surgical AI papers reveals that these pitfalls are widespread. Experiments on surgical video datasets show that ignoring temporal and hierarchical data structures can understate uncertainty, obscure critical failure modes, and alter algorithm rankings. To address these shortcomings, we provide consensus-based best practices compiled. Together, this work provides an evidence-based framework for rigorous validation of surgical video analysis algorithms, guiding benchmarking, reporting, regulatory review, and clinical translation.

q-bio.OT↗